Prevalence and management of eosinophilia based on periodic health examinations in primary care clinics

[1] Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017; 176:553–72. ButtNM LambertJ AliS BeerPA CrossNC DuncombeA Guideline for the investigation and management of eosinophilia Br J Haematol 2017 176 553 72 Search in Google Scholar

[2] Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol. 2006; 133:468–92. TefferiA PatnaikMM PardananiA Eosinophilia: secondary, clonal and idiopathic Br J Haematol 2006 133 468 92 Search in Google Scholar

[3] Andersen CL, Siersma VD, Hasselbalch HC, Lindegaard H, Vestergaard H, Felding P, et al. Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death. Am J Hematol. 2013; 88:843–7. AndersenCL SiersmaVD HasselbalchHC LindegaardH VestergaardH FeldingP Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death Am J Hematol 2013 88 843 7 Search in Google Scholar

[4] Kuang FL. Approach to patients with Eosinophilia. Med Clin North Am. 2020; 104:1–14. KuangFL Approach to patients with Eosinophilia Med Clin North Am 2020 104 1 14 Search in Google Scholar

[5] Andersen CL, Siersma VD, Hasselbalch HC, Vestergaard H, Mesa R, Felding P, et al. Association of the blood eosinophil count with hematological malignancies and mortality. Am J Hematol. 2015; 90:225–9. AndersenCL SiersmaVD HasselbalchHC VestergaardH MesaR FeldingP Association of the blood eosinophil count with hematological malignancies and mortality Am J Hematol 2015 90 225 9 Search in Google Scholar

[6] Brigden M, Graydon C. Eosinophilia detected by automated blood cell counting in ambulatory North American outpatients. Incidence and clinical significance. Arch Pathol Lab Med. 1997; 121:963–7. BrigdenM GraydonC Eosinophilia detected by automated blood cell counting in ambulatory North American outpatients. Incidence and clinical significance Arch Pathol Lab Med 1997 121 963 7 Search in Google Scholar

[7] Chaipokam J. Correlation of Eosinophilia in routine blood samples and clinical manifestationsin Sakon Nakhon Hospital. J Sakon Nakhon Hosp. 2018; 21:194–202. ChaipokamJ Correlation of Eosinophilia in routine blood samples and clinical manifestationsin Sakon Nakhon Hospital J Sakon Nakhon Hosp 2018 21 194 202 Search in Google Scholar

[8] Triteeraprapab S, Nuchprayoon I. Eosinophilia, anemia and parasitism in a rural region of northwest Thailand. Southeast Asian J Trop Med Public Health. 1998; 29:584–90. TriteeraprapabS NuchprayoonI Eosinophilia, anemia and parasitism in a rural region of northwest Thailand Southeast Asian J Trop Med Public Health 1998 29 584 90 Search in Google Scholar

[9] Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012; 49:149–59. doi: 10.1053/j.seminhematol.2012.01.006 MejiaR NutmanTB Evaluation and differential diagnosis of marked, persistent eosinophilia Semin Hematol 2012 49 149 59 10.1053/j.seminhematol.2012.01.006 Open DOISearch in Google Scholar

[10] Falchi L, Verstovsek S. Eosinophilia in hematologic disorders. Immunol Allergy Clin North Am. 2015; 35:439–52. FalchiL VerstovsekS Eosinophilia in hematologic disorders Immunol Allergy Clin North Am 2015 35 439 52 Search in Google Scholar

[11] Guo C, Bochner BS. Workup for eosinophilia. Allergy Asthma Proc. 2019; 40:429–32. GuoC BochnerBS Workup for eosinophilia Allergy Asthma Proc 2019 40 429 32 Search in Google Scholar

[12] Nordic MPN Study Group. Care program for the diagnosis and treatment of eosinophilia 3rd version [Internet]. 2018 [cited 2011 Jul 10]. Available from: http://www.nmpn.org/index.php/guidelines/18-care-program-for-the-diagnosis-and-treatment-of-eosinophilia-3rd-version-may-2018/file Nordic MPN Study Group Care program for the diagnosis and treatment of eosinophilia 3rd version [Internet] 2018 [cited 2011 Jul 10]. Available from: http://www.nmpn.org/index.php/guidelines/18-care-program-for-the-diagnosis-and-treatment-of-eosinophilia-3rd-version-may-2018/file Search in Google Scholar

[13] Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol. 2010; 126:39–44. RoufosseF WellerPF Practical approach to the patient with hypereosinophilia J Allergy Clin Immunol 2010 126 39 44 Search in Google Scholar

[14] Makkar A, Rohtagi A, Goel A, Sharma SK, Garg S, Narayan S, et al. A study of clinical profile and spontaneous course of eosinophilia. JK Sci. 2005; 7:199–201. MakkarA RohtagiA GoelA SharmaSK GargS NarayanS A study of clinical profile and spontaneous course of eosinophilia JK Sci 2005 7 199 201 Search in Google Scholar

[15] Wardlaw AJ, Wharin S, Aung H, Shaffu S, Siddiqui S. The causes of a peripheral blood eosinophilia in a secondary care setting. Clin Exp Allergy. 2021; 51:902–14. WardlawAJ WharinS AungH ShaffuS SiddiquiS The causes of a peripheral blood eosinophilia in a secondary care setting Clin Exp Allergy 2021 51 902 14 Search in Google Scholar

[16] Page KR, Zenilman J. Eosinophilia in a patient from South America. JAMA. 2008; 299:437–44. PageKR ZenilmanJ Eosinophilia in a patient from South America JAMA 2008 299 437 44 Search in Google Scholar

[17] Meltzer E, Percik R, Shatzkes J, Sidi Y, Schwartz E. Eosinophilia among returning travelers: a practical approach. Am J Trop Med Hyg. 2008; 78:702–9. MeltzerE PercikR ShatzkesJ SidiY SchwartzE Eosinophilia among returning travelers: a practical approach Am J Trop Med Hyg 2008 78 702 9 Search in Google Scholar

[18] Triteeraprapab S, Thamapanyawat B, Nuchprayoon I. Eosinophilia with low prevalence of parasitism in a rural area of Maha Sarakham province after annual mass treatment with mebendazole and albendazole. Chula Med J. 2000; 44:423–31. TriteeraprapabS ThamapanyawatB NuchprayoonI Eosinophilia with low prevalence of parasitism in a rural area of Maha Sarakham province after annual mass treatment with mebendazole and albendazole Chula Med J 2000 44 423 31 Search in Google Scholar

[19] Kobayashi S, Inokuma S, Setoguchi K, Kono H, Abe K. Incidence of peripheral blood eosinophilia and the threshold eosinophile count for indicating hypereosinophilia-associated diseases. Allergy. 2002; 57:950–6. KobayashiS InokumaS SetoguchiK KonoH AbeK Incidence of peripheral blood eosinophilia and the threshold eosinophile count for indicating hypereosinophilia-associated diseases Allergy 2002 57 950 6 Search in Google Scholar

[20] Wongsaroj T, Nithikathkul C, Rojkitikul W, Nakai W, Royal L, Rammasut P. National survey of helminthiasis in Thailand. Asian Biomed (Res Rev News). 2014; 8:779–83. WongsarojT NithikathkulC RojkitikulW NakaiW RoyalL RammasutP National survey of helminthiasis in Thailand Asian Biomed (Res Rev News) 2014 8 779 83 Search in Google Scholar

[21] Tarafder MR, Carabin H, Joseph L, Balolong E Jr, Olveda R, McGarvey ST. Estimating the sensitivity and specificity of Kato-Katz stool examination technique for detection of hookworms, Ascaris lumbricoides and Trichuris trichiura infections in humans in the absence of a ‘gold standard’. Int J Parasitol. 2010; 40:399–404. TarafderMR CarabinH JosephL BalolongEJr OlvedaR McGarveyST Estimating the sensitivity and specificity of Kato-Katz stool examination technique for detection of hookworms, Ascaris lumbricoides and Trichuris trichiura infections in humans in the absence of a ‘gold standard’ Int J Parasitol 2010 40 399 404 Search in Google Scholar

[22] Checkley AM, Chiodini PL, Dockrell DH, Bates I, Thwaites GE, Booth HL, et al. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect. 2010; 60:1–20. CheckleyAM ChiodiniPL DockrellDH BatesI ThwaitesGE BoothHL Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management J Infect 2010 60 1 20 Search in Google Scholar

[23] Ustianowski A, Zumla A. Eosinophilia in the returning traveler. Infect Dis Clin North Am. 2012; 26:781–9. UstianowskiA ZumlaA Eosinophilia in the returning traveler Infect Dis Clin North Am 2012 26 781 9 Search in Google Scholar

[24] Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of strongyloides infection. Am J Trop Med Hyg. 1995; 53:248–50. SatoY KobayashiJ TomaH ShiromaY Efficacy of stool examination for detection of strongyloides infection Am J Trop Med Hyg 1995 53 248 50 Search in Google Scholar

[25] Chai J-Y, Jung B-K, Hong S-J. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: an update. Korean J Parasitol. 2021; 59:189–225. ChaiJ-Y JungB-K HongS-J Albendazole and mebendazole as anti-parasitic and anti-cancer agents: an update Korean J Parasitol 2021 59 189 225 Search in Google Scholar

[26] Suputtamongkol Y, Premasathian N, Bhumimuang K, Waywa D, Nilganuwong S, Karuphong E, et al. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis. 2011; 5:e1044. SuputtamongkolY PremasathianN BhumimuangK WaywaD NilganuwongS KaruphongE Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis PLoS Negl Trop Dis 2011 5 e1044 Search in Google Scholar

[27] Sade K, Mysels A, Levo Y, Kivity S. Eosinophilia: a study of 100 hospitalized patients. Eur J Intern Med. 2007; 18:196–201. SadeK MyselsA LevoY KivityS Eosinophilia: a study of 100 hospitalized patients Eur J Intern Med 2007 18 196 201 Search in Google Scholar

[28] Chanswangphuwana C, Uaprasert N, Moonla C, Rojnuckarin P. Causes and outcomes of hypereosinophilia in a tropical country. Asian Pac J Allergy Immunol. 2021. doi: 10.12932/AP-221220-1021 ChanswangphuwanaC UaprasertN MoonlaC RojnuckarinP Causes and outcomes of hypereosinophilia in a tropical country Asian Pac J Allergy Immunol 2021 10.12932/AP-221220-1021 Open DOISearch in Google Scholar

[29] Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000; 121 Suppl:S113–32. HortonJ Albendazole: a review of anthelmintic efficacy and safety in humans Parasitology 2000 121 Suppl S113 32 Search in Google Scholar

[30] Klion AD. How I treat hypereosinophilic syndromes. Blood. 2009; 114:3736–41. KlionAD How I treat hypereosinophilic syndromes Blood 2009 114 3736 41 Search in Google Scholar